Anhui Fengyuan Pharmaceutical Co., Ltd. logo

Anhui Fengyuan Pharmaceutical Co., Ltd. (000153)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
5. 91
+0.07
+1.1986%
¥
3.09B Market Cap
15.35 P/E Ratio
0.6% Div Yield
16.65M Volume
0 Eps
¥ 5.84
Previous Close
Add Transaction
Day Range
5.76 6.02
Year Range
4.95 7.48
Want to track 000153 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000153 closed today higher at ¥5.91, an increase of 1.1986% from yesterday's close, completing a monthly increase of 16.568% or ¥0.84. Over the past 12 months, 000153 stock lost -6.1905%.
000153 pays dividends to its shareholders, with the most recent payment made on Jun 18, 2026. The next estimated payment will be in In 10 months on Jun 18, 2027 for a total of ¥0.1.
The last earnings report, released on May 22, 2025, exceeded the consensus estimates by 0.0818%. On average, the company has surpassed earnings expectations by 0.0956%, based on the last three reports.
Anhui Fengyuan Pharmaceutical Co., Ltd. has completed 3 stock splits, with the recent split occurring on Jun 07, 2024.
The company's stock is traded on one exchange.

000153 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Anhui Fengyuan Pharmaceutical Co., Ltd. (000153) FAQ

What is the stock price today?

The current price is ¥5.91.

On which exchange is it traded?

Anhui Fengyuan Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000153.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, the market cap is 3.09B.

Has Anhui Fengyuan Pharmaceutical Co., Ltd. ever had a stock split?

Anhui Fengyuan Pharmaceutical Co., Ltd. had 3 splits and the recent split was on Jun 07, 2024.

Anhui Fengyuan Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Tianle Ru CEO
XSHE Exchange
CNE0000014X5 ISIN
CN Country
4,542 Employees
18 Jun 2026 Last Dividend
21 Jun 2005 Last Split
7 Sep 2000 IPO Date

Overview

Anhui Fengyuan Pharmaceutical Co., Ltd., established in 1997 and headquartered in Hefei, China, is a prominent player in the pharmaceutical industry. The company is dedicated to the research and development, production, and sales of a wide range of pharmaceutical products. Its diverse portfolio includes biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and Active Pharmaceutical Ingredients (APIs). With a strong focus on the domestic market, Anhui Fengyuan Pharmaceutical has also made significant inroads in international markets, exporting products to Africa, Southeast Asia, Central Asia, Europe, and various other regions worldwide.

Products and Services

  • Gynecology: The company develops and offers a variety of pharmaceutical solutions tailored for women’s health, addressing conditions specific to the female reproductive system.
  • Respiratory System: Offering treatments aimed at alleviating and treating respiratory conditions, ensuring better breathing and lung health.
  • Hormonal: An array of products designed to balance and treat hormonal disorders, supporting endocrine health.
  • Antipyretic Analgesic: Medications focused on relieving fever and pain, catering to symptomatic relief for a variety of conditions.
  • Mental Class: A diverse range of drugs aimed at treating mental and neurological disorders, promoting mental health and well-being.
  • Antiviral Class: Dedicated to combating viral infections, these products are critical in the treatment and management of viral diseases.
  • Antibiotic Class: This category includes drugs designed to fight bacterial infections, essential in both acute and chronic disease management.
  • Oral Anesthetic: Products that provide local anesthesia, particularly used in dental procedures and pain relief in the oral cavity.
  • Masks Class: Besides pharmaceuticals, the company also ventures into medical supplies like masks, contributing to infection control.
  • Urinary: A range of products focused on urinary tract health, addressing conditions such as infections and bladder issues.
  • Water Electrolyte Balance: Solutions that help in maintaining the body’s electrolyte balance, crucial for metabolic functions and hydration.
  • Digestive System: Products designed to treat and manage digestive system disorders, promoting gastrointestinal health.
  • Cardiovascular Class: Medications aimed at treating cardiovascular diseases, improving heart health and circulation.
  • Yinpian Class: Traditional Chinese medicine pieces, emphasizing the use of natural herbs and components for therapeutic purposes.
  • Nutrition and Metabolism: Products that support nutritional well-being and metabolic health, addressing deficiencies and metabolic disorders.
  • Raw Material Drugs: Anhui Fengyuan Pharmaceutical also supplies Active Pharmaceutical Ingredients (APIs), catering to the broader pharmaceutical manufacturing sector.

Contact Information

Address: No.16 Dalian Road, Hefei, China
Phone: 86 551 6484 6195